Institut Bergonié

This study tests whether adding the immunotherapy drug retifanlimab to standard chemotherapy before surgery can improve outcomes for people with soft-tissue sarcoma. About 66 adults with grade 2 or 3 sarcoma that can be surgically removed will be randomly assigned to receive chem…

This study aimed to test a combination of chemotherapy and radiation for people with advanced non-small cell lung cancer that could not be removed by surgery. The treatment included chemotherapy before, during, and after radiation. However, the study was withdrawn before any part…

This study was planned to test two drugs, Ezabenlimab and BI 907828, in people with advanced solid tumors like sarcoma, lung, breast, colorectal, or bile duct cancer. The goal was to see if the combination could control tumor growth for at least 24 weeks. However, the study was w…

This study looks at whether a special ultrasound-guided biopsy can accurately tell if a uterine tumor is cancerous before surgery. About 19 women with suspicious tumors will get the biopsy, and results will be checked against the final diagnosis after surgery. If successful, this…

This study tests whether using a special monitor (ANI) during ovarian cancer surgery to guide pain medicine can lower the chance of chronic pain three months after the operation. About 126 women having open surgery for ovarian cancer will take part. The goal is to see if this app…

This study aimed to see if offering beauty treatments (like skincare or makeup) to women right after breast cancer surgery could improve how they feel about their bodies and their overall quality of life. It planned to compare women who received these treatments with those who di…

This study follows 25 adults aged 70 and older who had surgery for soft tissue sarcoma in the leg. Researchers measure changes in physical function and quality of life using standard questionnaires. The goal is to understand which factors most affect recovery and daily living aft…

This study was designed to observe and measure certain proteins (chemokines) in the blood, urine, and tumors of people with prostate cancer. The goal was to see how these protein levels change over time and relate to the disease. However, the study was withdrawn before any partic…

This study follows 430 people with a PTEN gene mutation (Cowden's disease) to better understand their risk of developing cancer. Researchers will track how many participants get cancer over time. The goal is to improve screening and care for this high-risk group.

This study brings together 265 experts to create clear, standard definitions for key measurements used in cancer clinical trials, such as how long patients live without their cancer getting worse. Currently, different trials define these measurements in different ways, making it …

This study aimed to understand how psychological and social factors might affect the risk of chronic pain after breast cancer surgery. It planned to follow women undergoing mastectomy or lumpectomy and measure pain levels over time. However, the study was withdrawn before startin…

This study aimed to see if MRI-guided focused ultrasound could safely destroy breast tumors before mastectomy. The treatment was planned under local anesthesia and sedation. However, the study was withdrawn before enrolling any participants, so no results are available.

This study looks at whether a remote monitoring tool can help track symptoms and quality of life in people over 65 being treated for cancer. About 33 participants will fill out weekly questionnaires about side effects and complete surveys on their well-being. The goal is to see i…

This study checks for muscle loss (sarcopenia) in 25 women with advanced ovarian cancer before they start chemotherapy. Researchers use CT scans to measure muscle mass and see how it relates to treatment timing. The goal is to better understand how muscle health affects care, not…